Literature DB >> 17971048

SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.

R K Burfoot1, C J Jensen, J Field, J Stankovich, M D Varney, L J Johnson, H Butzkueven, D Booth, M Bahlo, B D Tait, B V Taylor, T P Speed, R Heard, G J Stewart, S J Foote, T J Kilpatrick, J P Rubio.   

Abstract

This study is an extension to previously published work that has linked variation in the human leukocyte antigen (HLA) class I region with susceptibility to multiple sclerosis (MS) in Australians from the Island State of Tasmania. Single nucleotide polymorphism (SNP) mapping was performed on an 865-kb candidate region (D6S1683-D6S265) in 166 Tasmanian MS families, and seven candidate genes [ubiquitin D (UBD), olfactory receptor 2H3 (OR2H3), gamma-aminobutyric acid B receptor 1 (GABBR1), myelin oligodendrocyte glycoprotein (MOG), HLA-F, HLA complex group 4 (HCG4) and HLA-G] were resequenced. SNPs tagging the extended MS susceptibility haplotype were genotyped in an independent sample of 356 Australian MS trios and SNPs in the MOG gene were significantly over-transmitted to MS cases. We identified significant effects on MS susceptibility of HLA-A*2 (OR: 0.51; P = 0.05) and A*3 (OR: 2.85; P = 0.005), and two coding polymorphisms in the MOG gene (V145I: P = 0.01, OR: 2.2; V142L: P = 0.04, OR: 0.45) after full conditioning on HLA-DRB1. We have therefore identified plausible candidates for the causal MS susceptibility allele, and although not conclusive at this stage, our data provide suggestive evidence for multiple class I MS susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971048     DOI: 10.1111/j.1399-0039.2007.00962.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  17 in total

1.  A powerful association test of multiple genetic variants using a random-effects model.

Authors:  K F Cheng; J Y Lee; W Zheng; C Li
Journal:  Stat Med       Date:  2013-12-16       Impact factor: 2.373

2.  A single-nucleotide polymorphism of the STAT4 gene is associated with systemic lupus erythematosus (SLE) in female Chinese population.

Authors:  Haixia Luan; Ping Li; Chunwei Cao; Chaohua Li; Chaojun Hu; Shulan Zhang; Xiaofeng Zeng; Fengchun Zhang; Changqing Zeng; Yongzhe Li
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

3.  HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Authors:  B C Healy; M Liguori; D Tran; T Chitnis; B Glanz; C Wolfish; S Gauthier; G Buckle; M Houtchens; L Stazzone; S Khoury; R Hartzmann; M Fernandez-Vina; D A Hafler; H L Weiner; C R G Guttmann; P L De Jager
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

Review 4.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

5.  A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Authors:  Bruce A C Cree; John D Rioux; Jacob L McCauley; Pierre-Antoine F D Gourraud; Philippe Goyette; Joseph McElroy; Philip De Jager; Adam Santaniello; Timothy J Vyse; Peter K Gregersen; Daniel Mirel; David A Hafler; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen J Sawcer; Jorge R Oksenberg; Stephen L Hauser
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

6.  Rare variants create synthetic genome-wide associations.

Authors:  Samuel P Dickson; Kai Wang; Ian Krantz; Hakon Hakonarson; David B Goldstein
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

7.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Authors:  Sergio E Baranzini; Joanne Wang; Rachel A Gibson; Nicholas Galwey; Yvonne Naegelin; Frederik Barkhof; Ernst-Wilhelm Radue; Raija L P Lindberg; Bernard M G Uitdehaag; Michael R Johnson; Aspasia Angelakopoulou; Leslie Hall; Jill C Richardson; Rab K Prinjha; Achim Gass; Jeroen J G Geurts; Jolijn Kragt; Madeleine Sombekke; Hugo Vrenken; Pamela Qualley; Robin R Lincoln; Refujia Gomez; Stacy J Caillier; Michaela F George; Hourieh Mousavi; Rosa Guerrero; Darin T Okuda; Bruce A C Cree; Ari J Green; Emmanuelle Waubant; Douglas S Goodin; Daniel Pelletier; Paul M Matthews; Stephen L Hauser; Ludwig Kappos; Chris H Polman; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2008-11-14       Impact factor: 6.150

8.  Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia.

Authors:  Roberta Pastorino; Cristina Menni; Monserrata Barca; Luisa Foco; Valeria Saddi; Giovanna Gazzaniga; Raffaela Ferrai; Luca Mascaretti; Frank Dudbridge; Carlo Berzuini; Salvatore Bruno Murgia; Maria Luisa Piras; Anna Ticca; Pier Paolo Bitti; Luisa Bernardinelli
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

9.  HLA-class I markers and multiple sclerosis susceptibility in the Italian population.

Authors:  L Bergamaschi; M A Leone; M E Fasano; F R Guerini; D Ferrante; E Bolognesi; N Barizzone; L Corrado; P Naldi; C Agliardi; E Dametto; M Salvetti; A Visconti; D Galimberti; E Scarpini; M Vercellino; R Bergamaschi; F Monaco; D Caputo; P Momigliano-Richiardi; S D'Alfonso
Journal:  Genes Immun       Date:  2009-11-12       Impact factor: 2.676

Review 10.  What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

Authors:  Katherine A Buzzard; Simon A Broadley; Helmut Butzkueven
Journal:  Int J Mol Sci       Date:  2012-10-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.